2-[3-(diethylamino)propyl]-1-ethyl-3-(3,3,3-trifluoropropyl)guanidine;hydroiodide
C13H28F3IN4 — CID 109472410
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2-[3-(diethylamino)propyl]-1-ethyl-3-(3,3,3-trifluoropropyl)guanidine;hydroiodide
2-[3-(diethylamino)propyl]-1-ethyl-3-(3,3,3-trifluoropropyl)guanidine;hydroiodide (PubChem CID 109472410) has the molecular formula C13H28F3IN4 and a molecular weight of 424.29 g/mol. Its IUPAC name is 2-[3-(diethylamino)propyl]-1-ethyl-3-(3,3,3-trifluoropropyl)guanidine;hydroiodide.
Molecular Properties
| Compound Name | 2-[3-(diethylamino)propyl]-1-ethyl-3-(3,3,3-trifluoropropyl)guanidine;hydroiodide |
|---|---|
| PubChem CID | 109472410 |
| Molecular Formula | C13H28F3IN4 |
| Molecular Weight | 424.29 g/mol |
| Exact Mass | 424.13 |
| IUPAC Name | 2-[3-(diethylamino)propyl]-1-ethyl-3-(3,3,3-trifluoropropyl)guanidine;hydroiodide |
| SMILES | CCN/C(=N\CCCN(CC)CC)NCCC(F)(F)F.I |
| InChI | InChI=1S/C13H27F3N4.HI/c1-4-17-12(19-10-8-13(14,15)16)18-9-7-11-20(5-2)6-3;/h4-11H2,1-3H3,(H2,17,18,19);1H |
| InChIKey | VGNHECYMXZVQPD-UHFFFAOYSA-N |
| XLogP | 2.84 |
| TPSA | 39.66 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 2 |
| Rotatable Bonds | 9 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 424.29 |
| LogP ≤ 5 | 2.84 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 2 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}, {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'imine_2', 'substructure': 'N/A'}, {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 109472410 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.